Format

Send to

Choose Destination
J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):257-264. doi: 10.1097/QAI.0000000000002134.

PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.

Author information

1
Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada.
2
Département de Médecine Sociale et Préventive, Université Laval, Québec, Canada.
3
Currently, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
4
Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
5
Centre de Recherche de l'Hôpital Maisonneuve Rosemont, Montréal, Québec, Canada.
6
Currently, Prometic Biosciences, Inc., Laval, Québec, Canada.
7
Faculté des Sciences de la Santé, Université d'Abomey-Calavi, Cotonou, Bénin.
8
Centre National Hospitalier Universitaire HMK de Cotonou, Cotonou, Bénin.
9
Programme Santé de Lutte Contre le Sida (PSLS), Cotonou, Bénin.
10
Institut National de Santé Publique du Québec, Québec, Québec, Canada.

Abstract

BACKGROUND:

Little is known about risk compensation among female sex workers (FSW) on HIV pre-exposure prophylaxis (PrEP), and self-report of sexual behaviors is subject to bias.

SETTING:

Prospective observational PrEP demonstration study conducted among FSW in Cotonou, Benin.

METHODS:

Over a period of 24 months, we assessed and compared trends in unprotected sex as measured by self-report (last 2 or 14 days), by detection of sexually transmitted infections (STIs), and by vaginal detection of prostate-specific antigen and Y-chromosomal DNA, 2 biomarkers of semen exposure in the last 2 or 14 days, respectively. Trends were assessed and compared using a log-binomial regression that was simultaneously fit for all unprotected sex measures.

RESULTS:

Of 255 participants, 120 (47.1%) completed their follow-up. Prevalence of STI decreased from 15.8% (95% confidence interval: 11.8% to 21.0%) at baseline to 2.1% (95% confidence interval: 0.4% to 10.2%) at 24 months of follow-up (P-trend = 0.04). However, we observed no trend in self-report of unprotected sex in the last 2 (P = 0.42) or 14 days (P = 0.49), nor in prostate-specific antigen (P = 0.53) or Y chromosomal DNA (P = 0.25) over the same period. We observed no statistically significant difference between trends in self-report of unprotected sex and trends in biomarkers of semen exposure in the last 2 days (P = 0.14) or in the last 14 days (P = 0.29).

CONCLUSIONS:

We observed no evidence of risk compensation, and a decrease in STI among FSW on PrEP. PrEP intervention may be an opportunity to control STI among FSW. Future studies should assess risk compensation with biomarkers of semen exposure when possible.

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center